Vimarsana
Biggest News Aggregation in the World

Onclive Tv News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Onclive Tv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Onclive Tv Today - Breaking & Trending Today

Dr Obeng-Gyasi on Neighborhood Opportunity and Mortality in Breast Cancer - Vimarsana News

Dr Obeng-Gyasi on Neighborhood Opportunity and Mortality in Breast Cancer

Samilia Obeng-Gyasi, MD, MPH, discusses a retrospective study on neighborhood opportunity and all-cause mortality in patients with breast cancer.

Dr Jagannath on the ODAC Meeting on the Safety of Cilta-Cel in R/R Multiple Myeloma - Vimarsana News

Dr Jagannath on the ODAC Meeting on the Safety of Cilta-Cel in R/R Multiple Myeloma

Sundar Jagannath, MBBS, discusses takeaways from the FDA’s ODAC consensus on safety considerations with cilta-cel in relapsed/refractory multiple myeloma.

Dr Siefker-Radtke on Toxicities With Enfortumab Vedotin Plus Pembrolizumab in Bladder Cancer - Vimarsana News

Dr Siefker-Radtke on Toxicities With Enfortumab Vedotin Plus Pembrolizumab in Bladder Cancer

Arlene O. Siefker-Radtke, MD, discusses toxicities associated with enfortumab vedotin plus pembrolizumab in patients with bladder cancer.

Dr Lenz on the Association Between HER2 Expression and Treatment Outcomes in mCRC - Vimarsana News

Dr Lenz on the Association Between HER2 Expression and Treatment Outcomes in mCRC

Heinz-Josef Lenz, MD, FACP, discusses the association between HER2 expression and treatment outcomes in metastatic colorectal cancer.

Dr Cobain on Endocrine Therapy–Based Treatment Strategies in HR+/HER2– Breast Cancer - Vimarsana News

Dr Cobain on Endocrine Therapy–Based Treatment Strategies in HR+/HER2– Breast Cancer

Erin Frances Cobain, MD, discusses optimal endocrine therapy–based treatment strategies in later-line settings for HR-positive/HER2-negative breast cancer.